European Archives - Page 133 of 1268 - European Medical Journal

ERA 2025: New Biomarker Model Predicts Kidney Fibrosis in IgA Nephropathy

Selected as a top 10 abstract at the ERA Congress, this study unveils a new multiple biomarker model to predict tubulointerstitial fibrosis in IgA nephropathy without a biopsy.

Respiratory Microbiota Shifts with COVID-19 Severity Progression

New research reveals that the composition of the lower respiratory tract microbiota is closely linked to COVID-19 severity.

How Four Botox Options Differ for Frown Lines

The findings highlight that abobotulinum toxin A and prabotulinum toxin A demonstrated the quickest onset of action.

EMJ Allergy & Immunology 10 [Supplement 3] 2025

Angioedema (AE) syndromes are associated with recurrent, unpredictable attacks of subcutaneous and submucosal tissue swelling, which can…

Bradykinin and Angioedema

Angioedema (AE) syndromes are associated with recurrent, unpredictable attacks of subcutaneous and submucosal tissue swelling, which can…

GSK’s Dheepa Chari on the evolving sphere of scientific communication

Dheepa Chari joins EMJ GOLD to discuss her career path, AI in pharma and the future of scientific communication.

Transforming the Cath Lab: Interview with Arnold Seto

Transforming the Cath Lab: Interview with Arnold Seto Division of Cardiology, Long Beach Veterans Administration Healthcare System…

Illustration of kidneys

Vantive to invest $1bn in digital kidney care therapies

Vantive has announced the five-year, major investment to expand its R&D and manufacturing capabilities.

Treatment Outcomes in High-Grade NMIBC Compared

Discover a study that found that 22% of patients who underwent radical cystectomy were upstaged at surgery, leading to a lower 12-month progression-free survival rate.

Two men walking on arrows

Sanofi to acquire Blueprint in $9.1bn deal

Sanofi is set to acquire Blueprint Medicines, a US-based biopharmaceutical company specialising in systemic mastocytosis.